Skip to main content
Clinical Trials/NCT04902898
NCT04902898UnknownNot Applicable

Evaluation of the Safety and Efficacy of the Sterile Single-use Circular Stapling Device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) in Adult Patients Suffering From Pathologic Foreskin (Phimosis, Stenosis, Redundant Prepuce): A Prospective Randomised Comparative Clinical Trial

University of Thessaly2 sites in 1 country100 target enrollmentStarted: May 11, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Locations
2
Primary Endpoint
Bleeding

Study Overview

Brief Summary

Evaluation of the safety and efficacy of the sterile single-use circular stapling device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) in comparison with circumcision in adults patients with pathological foreskin (phimosis, stenosis, redundant prepuce)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
16 Years to 100 Years (Child, Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Bleeding

Time Frame: Intraoperatively

Number of gauzes used intraoperatively

Postoperative hematoma

Time Frame: Seventh postoperative day

Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation

Postoperative oedema

Time Frame: Twenty first postoperative day

Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation

Duration of procedure

Time Frame: Intraoperative (Measurement begins at the time of the beginning of the sterilisation of the surgical field and ends at the time of the completion of the bandeage of the wound)

Minutes

Secondary Outcomes

  • Postoperative oedema(Seventh postoperative day)
  • Aesthetic result(Nineteenth postoperative day)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vasileios Tzortzis

Professor of Urology

University of Thessaly

Study Sites (2)

Loading locations...

Similar Trials